Pfizer Inc. (PFE)
USD 25.89
(-2.04%)
USD 25.89
(-2.04%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 75.04 Billion USD | 115.2% |
| 2022 | 34.87 Billion USD | -5.75% |
| 2021 | 36.99 Billion USD | -3.33% |
| 2020 | 38.27 Billion USD | -26.6% |
| 2019 | 52.14 Billion USD | 26.37% |
| 2018 | 41.26 Billion USD | -3.15% |
| 2017 | 42.6 Billion USD | 1.24% |
| 2016 | 42.08 Billion USD | 7.97% |
| 2015 | 38.97 Billion USD | 6.26% |
| 2014 | 36.68 Billion USD | 0.53% |
| 2013 | 36.48 Billion USD | -2.59% |
| 2012 | 37.46 Billion USD | -3.82% |
| 2011 | 38.94 Billion USD | -11.55% |
| 2010 | 44.03 Billion USD | -9.51% |
| 2009 | 48.66 Billion USD | 181.56% |
| 2008 | 17.28 Billion USD | 31.54% |
| 2007 | 13.13 Billion USD | 64.65% |
| 2006 | 7.98 Billion USD | -55.51% |
| 2005 | 17.93 Billion USD | -3.28% |
| 2004 | 18.54 Billion USD | 27.26% |
| 2003 | 14.57 Billion USD | 23.41% |
| 2002 | 11.8 Billion USD | 33.07% |
| 2001 | 8.87 Billion USD | 63.97% |
| 2000 | 5.41 Billion USD | -2.06% |
| 1999 | 5.52 Billion USD | 69.72% |
| 1998 | 3.25 Billion USD | -3.61% |
| 1997 | 3.37 Billion USD | 15.61% |
| 1996 | 2.92 Billion USD | 1.87% |
| 1995 | 2.86 Billion USD | 1.57% |
| 1994 | 2.82 Billion USD | 61.45% |
| 1993 | 1.74 Billion USD | -4.07% |
| 1992 | 1.82 Billion USD | -12.65% |
| 1991 | 2.08 Billion USD | 23.34% |
| 1990 | 1.69 Billion USD | -1.42% |
| 1989 | 1.71 Billion USD | 43.72% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 69.45 Billion USD | -0.13% |
| 2024 Q3 | 58 Billion USD | -4.08% |
| 2024 Q1 | 69.53 Billion USD | -7.33% |
| 2023 Q1 | 35.89 Billion USD | 2.93% |
| 2023 Q4 | 75.04 Billion USD | 18.0% |
| 2023 Q3 | 63.59 Billion USD | -2.67% |
| 2023 Q2 | 65.34 Billion USD | 82.05% |
| 2023 FY | 75.04 Billion USD | 115.2% |
| 2022 Q3 | 35.67 Billion USD | -11.44% |
| 2022 Q1 | 35.05 Billion USD | -5.26% |
| 2022 Q2 | 40.28 Billion USD | 14.93% |
| 2022 FY | 34.87 Billion USD | -5.75% |
| 2022 Q4 | 34.87 Billion USD | -2.26% |
| 2021 Q3 | 38.4 Billion USD | 1.78% |
| 2021 Q4 | 36.99 Billion USD | -3.67% |
| 2021 FY | 36.99 Billion USD | -3.33% |
| 2021 Q2 | 37.73 Billion USD | -1.19% |
| 2021 Q1 | 38.18 Billion USD | -0.22% |
| 2020 FY | 38.27 Billion USD | -26.6% |
| 2020 Q1 | 52.28 Billion USD | 0.27% |
| 2020 Q2 | 63.61 Billion USD | 21.66% |
| 2020 Q3 | 61.52 Billion USD | -3.28% |
| 2020 Q4 | 38.27 Billion USD | -37.79% |
| 2019 Q2 | 46.67 Billion USD | 3.39% |
| 2019 Q1 | 45.14 Billion USD | 9.4% |
| 2019 Q3 | 52.65 Billion USD | 12.81% |
| 2019 Q4 | 52.14 Billion USD | -0.97% |
| 2019 FY | 52.14 Billion USD | 26.37% |
| 2018 Q2 | 40.52 Billion USD | -0.76% |
| 2018 Q3 | 48.43 Billion USD | 19.52% |
| 2018 Q4 | 41.26 Billion USD | -14.8% |
| 2018 FY | 41.26 Billion USD | -3.15% |
| 2018 Q1 | 40.83 Billion USD | -4.16% |
| 2017 Q3 | 43.95 Billion USD | 0.56% |
| 2017 Q2 | 43.7 Billion USD | -0.69% |
| 2017 FY | 42.6 Billion USD | 1.24% |
| 2017 Q1 | 44.01 Billion USD | 4.57% |
| 2017 Q4 | 42.6 Billion USD | -3.06% |
| 2016 Q2 | 44.18 Billion USD | 12.22% |
| 2016 FY | 42.08 Billion USD | 7.97% |
| 2016 Q1 | 39.37 Billion USD | 1.01% |
| 2016 Q3 | 44.07 Billion USD | -0.25% |
| 2016 Q4 | 42.08 Billion USD | -4.5% |
| 2015 FY | 38.97 Billion USD | 6.26% |
| 2015 Q1 | 35.92 Billion USD | -2.06% |
| 2015 Q3 | 38.89 Billion USD | 10.75% |
| 2015 Q4 | 38.97 Billion USD | 0.21% |
| 2015 Q2 | 35.12 Billion USD | -2.23% |
| 2014 Q4 | 36.68 Billion USD | -1.01% |
| 2014 Q3 | 37.05 Billion USD | -2.04% |
| 2014 Q2 | 37.82 Billion USD | 2.33% |
| 2014 FY | 36.68 Billion USD | 0.53% |
| 2014 Q1 | 36.96 Billion USD | 1.31% |
| 2013 Q2 | 36.74 Billion USD | -8.99% |
| 2013 FY | 36.48 Billion USD | -2.59% |
| 2013 Q3 | 36.55 Billion USD | -0.53% |
| 2013 Q4 | 36.48 Billion USD | -0.17% |
| 2013 Q1 | 40.37 Billion USD | 7.79% |
| 2012 FY | 37.46 Billion USD | -3.82% |
| 2012 Q4 | 37.46 Billion USD | -3.6% |
| 2012 Q3 | 38.85 Billion USD | 0.74% |
| 2012 Q1 | 39.06 Billion USD | 0.31% |
| 2012 Q2 | 38.57 Billion USD | -1.27% |
| 2011 FY | 38.94 Billion USD | -11.55% |
| 2011 Q3 | 41.03 Billion USD | -1.62% |
| 2011 Q2 | 41.71 Billion USD | 0.75% |
| 2011 Q1 | 41.4 Billion USD | -5.98% |
| 2011 Q4 | 38.94 Billion USD | -5.09% |
| 2010 Q1 | 46.05 Billion USD | -5.37% |
| 2010 FY | 44.03 Billion USD | -9.51% |
| 2010 Q4 | 44.03 Billion USD | -0.31% |
| 2010 Q3 | 44.16 Billion USD | 2.07% |
| 2010 Q2 | 43.27 Billion USD | -6.03% |
| 2009 Q2 | 46.53 Billion USD | 31.29% |
| 2009 Q1 | 35.44 Billion USD | 105.1% |
| 2009 FY | 48.66 Billion USD | 181.56% |
| 2009 Q3 | 46.19 Billion USD | -0.73% |
| 2009 Q4 | 48.66 Billion USD | 5.33% |
| 2008 Q3 | 16.34 Billion USD | -2.09% |
| 2008 Q1 | 17.05 Billion USD | 29.78% |
| 2008 Q2 | 16.69 Billion USD | -2.1% |
| 2008 FY | 17.28 Billion USD | 31.54% |
| 2008 Q4 | 17.28 Billion USD | 5.74% |
| 2007 Q2 | 8.2 Billion USD | 10.8% |
| 2007 Q4 | 13.13 Billion USD | 51.27% |
| 2007 FY | 13.13 Billion USD | 64.65% |
| 2007 Q1 | 7.4 Billion USD | -7.16% |
| 2007 Q3 | 8.68 Billion USD | 5.81% |
| 2006 Q4 | 7.98 Billion USD | -1.1% |
| 2006 FY | 7.98 Billion USD | -55.51% |
| 2006 Q1 | 11.56 Billion USD | -35.51% |
| 2006 Q2 | 9.22 Billion USD | -20.21% |
| 2006 Q3 | 8.06 Billion USD | -12.57% |
| 2005 Q2 | 12.77 Billion USD | -35.57% |
| 2005 Q1 | 19.83 Billion USD | 6.93% |
| 2005 FY | 17.93 Billion USD | -3.28% |
| 2005 Q4 | 17.93 Billion USD | 47.71% |
| 2005 Q3 | 12.14 Billion USD | -4.97% |
| 2004 Q2 | 18.96 Billion USD | 6.35% |
| 2004 Q4 | 18.54 Billion USD | -1.43% |
| 2004 Q1 | 17.83 Billion USD | 22.39% |
| 2004 FY | 18.54 Billion USD | 27.26% |
| 2004 Q3 | 18.81 Billion USD | -0.82% |
| 2003 Q3 | 15.83 Billion USD | 6.1% |
| 2003 FY | 14.57 Billion USD | 23.41% |
| 2003 Q1 | 12.97 Billion USD | 9.9% |
| 2003 Q2 | 14.92 Billion USD | 14.99% |
| 2003 Q4 | 14.57 Billion USD | -7.97% |
| 2002 Q4 | 11.8 Billion USD | -14.48% |
| 2002 Q3 | 13.8 Billion USD | 20.72% |
| 2002 Q2 | 11.43 Billion USD | 10.77% |
| 2002 Q1 | 10.32 Billion USD | 16.36% |
| 2002 FY | 11.8 Billion USD | 33.07% |
| 2001 Q1 | 5.85 Billion USD | 8.11% |
| 2001 Q2 | 7 Billion USD | 19.72% |
| 2001 Q4 | 8.87 Billion USD | 5.03% |
| 2001 Q3 | 8.44 Billion USD | 20.61% |
| 2001 FY | 8.87 Billion USD | 63.97% |
| 2000 Q2 | 6.81 Billion USD | 60.58% |
| 2000 FY | 5.41 Billion USD | -2.06% |
| 2000 Q4 | 5.41 Billion USD | -24.74% |
| 2000 Q3 | 7.19 Billion USD | 5.59% |
| 2000 Q1 | 4.24 Billion USD | -23.25% |
| 1999 Q2 | 5.46 Billion USD | 13.42% |
| 1999 Q4 | 5.52 Billion USD | -8.07% |
| 1999 FY | 5.52 Billion USD | 69.72% |
| 1999 Q1 | 4.82 Billion USD | 48.07% |
| 1999 Q3 | 6.01 Billion USD | 9.93% |
| 1998 Q3 | 3.87 Billion USD | 17.27% |
| 1998 FY | 3.25 Billion USD | -3.61% |
| 1998 Q1 | 3.24 Billion USD | -3.97% |
| 1998 Q2 | 3.3 Billion USD | 1.94% |
| 1998 Q4 | 3.25 Billion USD | -16.04% |
| 1997 Q4 | 3.37 Billion USD | -5.64% |
| 1997 Q1 | 3.31 Billion USD | 13.42% |
| 1997 Q2 | 3.7 Billion USD | 11.92% |
| 1997 Q3 | 3.58 Billion USD | -3.48% |
| 1997 FY | 3.37 Billion USD | 15.61% |
| 1996 Q4 | 2.92 Billion USD | -21.24% |
| 1996 Q3 | 3.71 Billion USD | 18.61% |
| 1996 Q2 | 3.12 Billion USD | 7.01% |
| 1996 FY | 2.92 Billion USD | 1.87% |
| 1996 Q1 | 2.92 Billion USD | 1.9% |
| 1995 Q2 | 3.67 Billion USD | -1.46% |
| 1995 FY | 2.86 Billion USD | 1.57% |
| 1995 Q1 | 3.72 Billion USD | 31.9% |
| 1995 Q3 | 3.4 Billion USD | -7.25% |
| 1995 Q4 | 2.86 Billion USD | -15.75% |
| 1994 Q1 | 2.08 Billion USD | 19.36% |
| 1994 Q2 | 2.4 Billion USD | 15.25% |
| 1994 Q4 | 2.82 Billion USD | 18.51% |
| 1994 FY | 2.82 Billion USD | 61.45% |
| 1994 Q3 | 2.38 Billion USD | -0.97% |
| 1993 Q4 | 1.74 Billion USD | -37.37% |
| 1993 Q2 | 2.73 Billion USD | 13.31% |
| 1993 FY | 1.74 Billion USD | -4.07% |
| 1993 Q1 | 2.41 Billion USD | 32.36% |
| 1993 Q3 | 2.79 Billion USD | 2.12% |
| 1992 Q3 | 1.86 Billion USD | 13.9% |
| 1992 Q1 | 1.87 Billion USD | -10.34% |
| 1992 Q2 | 1.63 Billion USD | -12.57% |
| 1992 Q4 | 1.82 Billion USD | -2.17% |
| 1992 FY | 1.82 Billion USD | -12.65% |
| 1991 Q4 | 2.08 Billion USD | 14.9% |
| 1991 FY | 2.08 Billion USD | 23.34% |
| 1991 Q1 | 1.43 Billion USD | -15.01% |
| 1991 Q2 | 1.71 Billion USD | 19.25% |
| 1991 Q3 | 1.81 Billion USD | 5.91% |
| 1990 Q1 | 1.17 Billion USD | -31.28% |
| 1990 Q4 | 1.69 Billion USD | 16.88% |
| 1990 Q2 | 1.27 Billion USD | 7.71% |
| 1990 FY | 1.69 Billion USD | -1.42% |
| 1990 Q3 | 1.44 Billion USD | 13.96% |
| 1989 FY | 1.71 Billion USD | 43.72% |
| 1989 Q4 | 1.71 Billion USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AbbVie Inc. | 59.38 Billion USD | -26.364% |
| Bristol-Myers Squibb Company | 41.46 Billion USD | -80.979% |
| Bristol-Myers Squibb Company Ce | 41.46 Billion USD | -80.979% |
| Johnson & Johnson | 29.33 Billion USD | -155.833% |
| Eli Lilly and Company | 25.22 Billion USD | -197.483% |
| Merck & Co., Inc. | 36.26 Billion USD | -106.907% |
| Novartis AG | 26.34 Billion USD | -184.807% |
| Organon & Co. | 8.76 Billion USD | -756.632% |